AMGN

AMGEN Inc

Feb 05 • 04:00PM ET

367.80

+1.60 0.44 %

Healthcare • Drug Manufacturers - General • USA • NASD

Peers: BIIB GILD REGN VRTX BMY MRNA ILMN PFE NBIX ABBV

| Held by: VTI VOO QQQ SCHD IVV SPY DIA VTV XLV VIG

Index	DJIA, NDX, S&P 500	P/E	25.85	EPS (ttm)	14.23	Insider Own	0.19%	Shs Outstand	539.00M	Perf Week	7.25%
Market Cap	198.05B	Forward P/E	15.77	EPS next Y	23.32	Insider Trans	-1.18%	Shs Float	537.46M	Perf Month	11.40%
Enterprise Value	243.53B	PEG	4.51	EPS next Q	4.83	Inst Own	81.44%	Short Float	2.60%	Perf Quarter	23.96%
Income	7.71B	P/S	5.39	EPS this Y	2.26%	Inst Trans	-0.50%	Short Ratio	4.76	Perf Half Y	29.20%
Sales	36.71B	P/B	22.90	EPS next Y	4.42%	ROA	8.45%	Short Interest	13.96M	Perf YTD	12.37%
Book/sh	16.06	P/C	21.69	EPS next 5Y	3.50%	ROE	106.10%	52W High	368.75 -0.26%	Perf Year	27.26%
Cash/sh	16.95	P/FCF	17.16	EPS past 3/5Y	5.52% 2.94%	ROIC	13.14%	52W Low	261.43 40.69%	Perf 3Y	45.72%
Dividend Est.	10.26 (2.79%)	EV/EBITDA	15.53	Sales past 3/5Y	12.10% 7.80%	Gross Margin	81.43%	Volatility	3.55% 2.83%	Perf 5Y	52.34%
Dividend TTM	9.52 (2.59%)	EV/Sales	6.63	EPS Y/Y TTM	88.13%	Oper. Margin	27.92%	ATR (14)	9.67	Perf 10Y	147.93%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	0.90	Sales Y/Y TTM	10.47%	Profit Margin	21.00%	RSI (14)	69.64	Recom	2.26
Dividend Gr. 3/5Y	7.05% 8.27%	Current Ratio	1.14	EPS Q/Q	111.79%	SMA20	8.06%	Beta	0.45	Target Price	349.36
Payout	66.90%	Debt/Eq	6.31	Sales Q/Q	9.08%	SMA50	10.02%	Rel Volume	1.35	Prev Close	366.20
Employees	28000	LT Debt/Eq	5.78	Earnings	Feb 03 AMC	SMA200	21.62%	Avg Volume	2.93M	Price	367.80
IPO	Jun 17, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.74% 4.14%	Trades		Volume	4,007,341	Change	0.44%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-20-26	Downgrade	Bernstein	Outperform → Mkt Perform	$335
Jan-07-26	Resumed	UBS	Buy	$380
Dec-05-25	Upgrade	Erste Group	Hold → Buy
Nov-24-25	Resumed	Truist	Hold	$318
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$385
Sep-03-25	Resumed	Raymond James	Mkt Perform
May-20-25	Resumed	Guggenheim	Neutral	$288
Apr-22-25	Resumed	Cantor Fitzgerald	Neutral	$305
Dec-10-24	Resumed	BofA Securities	Underperform	$256
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-14-24	Initiated	Citigroup	Neutral	$335
Oct-17-24	Initiated	Bernstein	Outperform	$380
Oct-14-24	Downgrade	Truist	Buy → Hold	$320 → $333
Sep-27-24	Initiated	Cantor Fitzgerald	Overweight	$405
Aug-07-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$320 → $335
May-03-24	Upgrade	William Blair	Mkt Perform → Outperform
May-03-24	Upgrade	Barclays	Underweight → Equal Weight	$230 → $300
Mar-28-24	Resumed	Raymond James	Mkt Perform
Feb-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$324 → $318
Dec-21-23	Upgrade	Daiwa Securities	Neutral → Buy	$264 → $320

Show Previous Ratings

Feb-05-26 05:03PM	Health Care Roundup: Market Talk (The Wall Street Journal)
02:23PM	RBC Lifts Amgen (AMGN) Target After Strong Q4, Cites Key Drug Momentum (Insider Monkey)
10:08AM	Zacks Investment Ideas feature highlights: Amgen, Apple and Microsoft (Zacks)
06:32AM	Generate, an AI-driven Flagship startup, pitches an IPO (BioPharma Dive)
03:40AM	Stock Market News for Feb 5, 2026 (Zacks)
03:00AM	Loading…
03:00AM	The most valuable up-and-coming GLP-1s (Pharma Voice)
03:00AM	Big Pharmas most valuable up-and-coming GLP-1s (Pharma Voice)
Feb-04-26 06:23PM	Rotation Trade a Boon for Dow 30 Today (Zacks) +8.15%
05:06PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:57PM	Stock Market Today: Nasdaq Sinks As Tech Sell-Off Intensifies; Alphabet Beats Wall Street Forecasts (Live Coverage) (Investor's Business Daily)
04:43PM	Broader Market Falls as Chipmakers and AI Stocks Tumble (Barchart)
04:23PM	Nasdaq, S&P 500 Settle Lower on Extended Tech Rotation (Schaeffer's Research)
04:09PM	Amgen Tops Buy Zone On Positive 2026 Outlook Amid Sharpening Obesity Focus (Investor's Business Daily)
02:35PM	Amgen (AMGN) Stock Hits 52-Week Highs: Buy Signal? (Zacks)
12:21PM	Today's Market: Dow Climbs 350 Points, Nasdaq Falls 1% as Tech Stocks Struggle (GuruFocus.com)
11:51AM	Loading…
11:51AM	Stock Market Today: Dow Rises, Nasdaq Sinks Amid Tech Sell-Off; AMD, Uber Dive (Live Coverage) (Investor's Business Daily)
11:36AM	Amgen Hits Buy Zone On Positive 2026 Outlook Amid Sharpening Obesity Focus (Investor's Business Daily)
10:19AM	AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus (Zacks)
10:16AM	Stock Market Today: Dow Rises But Nasdaq Lags On Surprise Jobs Data; Eli Lilly Soars (Live Coverage) (Investor's Business Daily)
09:51AM	Analyst Report: Amgen Inc. (Morningstar Research)
09:30AM	Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook (Zacks)
08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
04:51AM	Earnings roundup: Amgen vs. FDA, Pfizers defense and Mercks $70B-in-sales plan (BioPharma Dive)
12:32AM	AMGN Q4 Deep Dive: Product Portfolio Expansion and Pipeline Progress Drive Outlook (StockStory)
12:03AM	Amgen Inc (AMGN) Q4 2025 Earnings Call Highlights: Blockbuster Growth and Strategic Challenges (GuruFocus.com)
Feb-03-26 06:10PM	Amgen (AMGN) Q4 2025 Earnings Call Transcript (Motley Fool)
06:07PM	Amgen Q4 Earnings Call Highlights (MarketBeat)
06:00PM	Here's What Key Metrics Tell Us About Amgen (AMGN) Q4 Earnings (Zacks)
05:47PM	Markets Rotate Back Out of Tech, Q4 Earnings After the Close (Zacks)
05:10PM	Amgen (AMGN) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:07PM	Loading…
05:07PM	Amgen Eyes Buy Zone After Fourth-Quarter Beat As Obesity Studies Mount (Investor's Business Daily)
04:58PM	Amgens Revenue Climbs on Double-Digit Volume Boost (The Wall Street Journal)
04:58PM	Amgen Logs Higher Fourth-Quarter Revenue on Double-Digit Volume Boost (The Wall Street Journal)
04:41PM	Amgen beats Q4 expectations with 9% revenue growth, issues strong 2026 guidance (Investing.com)
04:13PM	Amgen (NASDAQ:AMGN) Reports Upbeat Q4 CY2025 (StockStory)
04:07PM	Amgen: Q4 Earnings Snapshot (Associated Press Finance)
04:04PM	Amgen quarterly results beat Street estimates on higher sales, lower tax rate (Reuters)
04:01PM	AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS (PR Newswire)
11:18AM	Silver Economy Boom: Investing in Healthcare's Aging Tailwinds (Zacks)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
07:24AM	Jim Cramer on Amgen: "The Biotech Really Impressed Me With a Very Strong Pipeline" (Insider Monkey)
06:26AM	Nasdaq Futures Climb on Blowout Palantir Results (Barchart)
05:00AM	Advanced Micro Devices heads earnings slate (MarketWatch)
04:19AM	Stock Market Today: S&P 500 eyes fresh record as Dow and Nasdaq also called higher; Palantir rises after earnings; gold and silver rebound; AMD results on tap. (MarketWatch)
Feb-02-26 07:00PM	AMD earnings, Netflix-Warner Bros. hearing: What to Watch (Yahoo Finance Video)
09:00AM	Amgen Stock: Is Wall Street Bullish or Bearish? (Barchart)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
06:59AM	Amgen hands back eczema drug to Kyowa Kirin despite positive late-stage data (Pharmaceutical Technology)
Feb-01-26 10:11PM	Amgen (AMGN) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-31-26 08:21AM	Kyowa Kirin to regain control of rocatinlimab development, commercialization (TipRanks)
Jan-30-26 01:09PM	Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends (Benzinga)
11:15AM	Dow Jones Leader Amgen Leads These Biotech Stocks Heading Into Q4 Earnings Season (Investor's Business Daily)
06:57AM	Amgen gives up on its once-prized eczema drug (BioPharma Dive)
Jan-29-26 12:24PM	UBS Raises Amgen (AMGN) Target as Pharma and Biotech Setup Improves (Insider Monkey)
09:40AM	Amgen (AMGN) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
09:15AM	Countdown to Amgen (AMGN) Q4 Earnings: Wall Street Forecasts for Key Metrics (Zacks)
Jan-28-26 08:50PM	Missed Out on Eli Lilly? This GLP-1 Stock Could Be a Bargain Buy. (Motley Fool)
04:01PM	AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS (PR Newswire)
12:47PM	Pharma Stocks Are Close to 'Breaking Out.' Earnings Could Set Them Free. (Barrons.com)
11:24AM	Amgen Set to Report Q4 Earnings: What Investors Should Know (Zacks)
11:10AM	Should You Stay Invested in J&J Stock After Q4 Beat & Solid Guidance? (Zacks)
10:00AM	Earnings Preview: Qiagen (QGEN) Q4 Earnings Expected to Decline (Zacks)
Jan-27-26 10:51AM	J&J Targets $100B+ Sales in 2026 as Growth Accelerates in Both Units (Zacks)
10:00AM	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for (Zacks)
04:10AM	Roche Obesity Shot Helps Patients Lose Weight in Midstage Trial (The Wall Street Journal)
01:52AM	Bernstein Calls 2026 a "Waiting Year" for Amgen's (AMGN) MariTide (Insider Monkey)
Jan-26-26 05:50PM	Amgen (AMGN) Laps the Stock Market: Here's Why (Zacks)
09:50AM	Here's Why Amgen (AMGN) is a Strong Momentum Stock (Zacks)
Jan-25-26 10:31PM	Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks (StockStory)
Jan-23-26 01:53PM	Dow Jones Stocks: Nvidia, Amgen Are Near Buy Points But This Longtime Loser Is Winning The Week (Investor's Business Daily)
09:00AM	Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock (Zacks)
04:34AM	CFOs On the Move: Week ending Jan. 23 (CFO.com)
Jan-22-26 06:00PM	Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know (Zacks)
11:01AM	Stock Market Today: Dow Up On GDP; Amgen Jumps To New Highs, As Abbott Gets Crushed (Live Coverage) (Investor's Business Daily)
09:26AM	Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y (Zacks)
Jan-21-26 02:36PM	Stock Market Today: S&P 500 Higher After Trump Davos News; Johnson & Johnson Slides (Live Coverage) (Investor's Business Daily)
01:04PM	UPS to build massive $6.1M cooler in Louisville. Here's what we know (The Courier Journal)
10:28AM	J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales (Zacks)
07:11AM	Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies (Insider Monkey)
Jan-20-26 11:34AM	Nonprofit Health Services Organization Files Lawsuit Against Fortune 500 Pharmaceutical Company Over Prescription Drug Access (Business Wire)
Jan-19-26 03:23PM	Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All (MarketBeat)
02:18PM	2 Dividend Stocks to Buy and Hold For 10 Years (Motley Fool)
09:07AM	Should You Buy, Sell or Hold J&J Stock Ahead of Q4 Results? (Zacks)
08:01AM	Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus (Zacks)
Jan-16-26 03:55PM	Ahead of the Quantinuum IPO, Should You Buy Honeywell Stock? (Barchart)
Jan-15-26 04:40PM	Amgen's Weight-Loss Drug Shows Promise With Less Frequent Dosing (Barrons.com)
01:52PM	Amgen Inc. (AMGN): A Bull Case Theory (Insider Monkey)
Jan-14-26 05:50PM	Amgen (AMGN) Advances While Market Declines: Some Information for Investors (Zacks)
12:36PM	Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses (Benzinga)
08:41AM	Quantum Computing Stocks: Honeywell's Quantinuum Plans IPO (Investor's Business Daily)
Jan-13-26 08:14PM	Amgen CEO: There are a bunch of ways to win for patients when it comes to weight loss (CNBC TV)
08:14PM	Amgen CEO Bob Bradway goes one-on-one with Jim Cramer (CNBC TV)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-12-26 11:37PM	1 Healthcare Stock to Keep an Eye On and 2 We Ignore (StockStory)
08:05PM	Amgen Calls 2026 a Springboard Year as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event (MarketBeat)
04:21PM	Expect a Busy Year in Obesity Drugs as New Pills Hit the Market (Barrons.com)
09:00AM	Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-09-26 09:13AM	Betting on More Rate Cuts, Boomers Are Buying the 2026 Small Dogs of the Dow (24/7 Wall St.)

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Option Exercise	169.70	3,139	532,691	8,864	Nov 21 08:34 PM
Grygiel Nancy A.	SVP & CCO	Nov 20 '25	Sale	337.26	3,139	1,058,667	7,225	Nov 21 08:34 PM
Grygiel Nancy A.	Officer	Nov 20 '25	Proposed Sale	337.26	3,139	1,058,667		Nov 20 04:45 PM
Khosla Rachna	SVP, Business Development	Nov 12 '25	Sale	336.24	890	299,256	7,082	Nov 13 07:29 PM
Gordon Murdo	EVP, Global Commercial Ops	Nov 12 '25	Sale	336.83	6,879	2,317,071	41,923	Nov 13 07:28 PM
Gordon Murdo	Officer	Nov 12 '25	Proposed Sale	337.23	6,879	2,319,805		Nov 12 03:02 PM
Khosla Rachna	Officer	Nov 12 '25	Proposed Sale	337.42	890	300,304		Nov 12 02:50 PM
Grygiel Nancy A.	SVP & CCO	Aug 20 '25	Sale	296.99	1,267	376,280	7,209	Aug 22 07:21 PM
Grygiel Nancy A.	Officer	Aug 20 '25	Proposed Sale	294.32	1,267	372,909		Aug 20 04:31 PM
Khosla Rachna	SVP, Business Development	Jun 05 '25	Sale	289.68	1,500	434,520	8,162	Jun 06 07:49 PM
Khosla Rachna	Officer	Jun 05 '25	Proposed Sale	290.00	1,500	435,000		Jun 05 12:24 PM
Busch Matthew C.	VP, Finance & CAO	May 02 '25	Sale	279.69	1,000	279,690	4,034	May 06 08:07 PM
Busch Matthew C.	Officer	May 02 '25	Proposed Sale	281.44	1,000	281,440		May 02 02:37 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	80,257	Feb 21 08:07 PM
Santos Esteban	EVP, Operations	Feb 19 '25	Sale	292.84	8,711	2,550,903	71,546	Feb 21 08:07 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Option Exercise	156.35	8,711	1,361,965	70,858	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 21 '25	Sale	304.44	25,225	7,679,524	36,922	Feb 21 08:06 PM
REESE DAVID M	EVP & Chief Technology Officer	Feb 19 '25	Sale	293.22	8,711	2,554,224	62,147	Feb 21 08:06 PM
DAVID M REESE & JOAN I CHUCO-T	Officer	Feb 21 '25	Proposed Sale	304.44	25,225	7,679,524		Feb 21 04:27 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Option Exercise	156.35	1,524	238,277	10,068	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 19 '25	Sale	293.74	1,524	447,655	8,544	Feb 20 08:59 PM
Miller Derek	SVP, Human Resources	Feb 18 '25	Sale	292.56	500	146,279	8,544	Feb 20 08:59 PM
DEREK MILLER	Officer	Feb 19 '25	Proposed Sale	293.74	1,524	447,655		Feb 19 04:18 PM
DAVID REESE	Officer	Feb 19 '25	Proposed Sale	293.22	8,711	2,554,224		Feb 19 04:14 PM
Santos Esteban	Affiliate	Feb 19 '25	Proposed Sale	292.11	8,711	2,544,570		Feb 19 02:25 PM
DEREK MILLER	Officer	Feb 18 '25	Proposed Sale	292.56	500	146,279		Feb 18 04:10 PM
Gordon Murdo	EVP, Global Commercial Ops	Feb 11 '25	Sale	294.79	8,771	2,585,644	44,186	Feb 13 09:02 PM
Gordon Murdo	Officer	Feb 11 '25	Proposed Sale	295.30	8,771	2,590,076		Feb 11 03:01 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Option Exercise	156.35	25,045	3,915,786	54,032	Feb 10 09:52 PM
Graham Jonathan P	EVP & Gen. Counsel & Secy.	Feb 07 '25	Sale	293.12	25,045	7,341,123	28,987	Feb 10 09:52 PM
Graham Jonathan P	Officer	Feb 07 '25	Proposed Sale	292.94	25,045	7,336,682		Feb 07 03:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMGN

AMGEN Inc

Upgrade your FINVIZ experience